文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

先筛查后接种:通过新生儿免疫缺陷筛查提升结核疫苗接种安全性

Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening.
PubMed 文献 · Vaccine · 2025-09-03

斯洛文尼亚于2024年引入新生儿先天性免疫缺陷(IEI)普遍筛查,并于2025年修订新生儿卡介苗(BCG)接种方案,将筛查结果纳入接种决策:采血在出生≥48小时进行,结果在出生后5-7天可获得,BCG在出生后7-14天接种。该模式在及时提供结核保护与保障高危婴儿安全之间取得平衡,或可为其他低发病率国家提供参考。

要点

  • 斯洛文尼亚2024年实施新生儿IEI普遍筛查,2025年修订BCG接种方案,将筛查结果用于接种前评估。
  • 该方案要求出生≥48小时采血,结果在出生后5-7天获得,BCG在出生后7-14天接种。
  • 该模式将实时免疫遗传数据与靶向BCG接种相结合,或可为其他低发病率国家提供参考。

核心结论

  • 斯洛文尼亚将新生儿IEI筛查结果整合进BCG接种决策,形成兼顾及时结核保护与高危婴儿安全的精准接种策略,或可为其他低发病率国家提供参考。

研究设计与样本

  • 本文为针对斯洛文尼亚新生儿IEI筛查与BCG接种方案修订的经验介绍,未报告样本量。
  • 斯洛文尼亚于2024年引入新生儿IEI普遍筛查,并于2025年修订新生儿BCG接种方案以纳入筛查结果。

主要发现

  • BCG对婴儿期重症结核提供强保护,但对青少年和成人肺结核病的效力有限。
  • BCG在免疫缺陷新生儿中具有播散性感染风险,凸显将免疫缺陷筛查整合进接种策略的重要性。

关键数值与推荐

  • 该方案要求出生≥48小时采血,结果在出生后5-7天可获得,BCG在出生后7-14天接种。

临床怎么用

  • 作者认为该斯洛文尼亚经验是一种精准接种策略,将实时免疫遗传数据与靶向BCG接种相结合。
  • 作者认为该策略符合世界卫生组织在等待下一代疫苗期间推动结核病预防现代化的目标,并或可为其他低发病率国家提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis (TB) remains a global health challenge, with around 10 million new cases reported annually and multidrug-resistant strains complicating control efforts. Although incidence has declined in many high-income regions, neonatal populations remain vulnerable, underscoring the continued role of Bacillus Calmette-Guérin (BCG) vaccination. BCG vaccination provides strong protection against severe forms of TB in infancy, though its efficacy against pulmonary disease in adolescents and adults is modest. However, the BCG vaccine carries a risk of disseminated infection in immunocompromised newborns, emphasizing the importance of integrating immunodeficiency screening into vaccination strategies. Slovenia introduced universal newborn screening for inborn errors of immunity (IEI) in 2024 and, in 2025, revised its neonatal BCG vaccination protocol to incorporate screening results before vaccination. Under this approach, blood sampling occurs at ≥48 h, results are available by days 5-7, and BCG is administered between 7 and 14 days of life. This model balances timely TB protection with safety for at-risk infants. The Slovenian experience exemplifies a precision vaccination strategy that integrates real-time immunogenetic data with targeted BCG administration. This approach aligns with World Health Organization goals to modernize TB prevention while awaiting next-generation vaccines and may serve as a guide for other low-incidence countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nosan G, Cerkvenik Škafar A. Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening. Vaccine. 2025. PMID: 40907067. doi:10.1016/j.vaccine.2025.127679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。